BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29446085)

  • 101. Polymorphism at the tumour necrosis factor locus: a marker of genetic predisposition to colorectal cancer?
    Campbell DA; Field M; McArdle CS; Cooke TG; Gallagher G
    Lancet; 1996 Jun; 347(9016):1706. PubMed ID: 8643009
    [No Abstract]   [Full Text] [Related]  

  • 102. One SNP for both cancer risk and survival in colorectal cancer: two for the price of one?
    Innocenti F
    Pharmacogenomics; 2012 Jul; 13(10):1114. PubMed ID: 23077730
    [No Abstract]   [Full Text] [Related]  

  • 103.
    Meng Q; Wu S; Wang Y; Xu J; Sun H; Lu R; Gao N; Yang H; Li X; Tang B; Aschner M; Chen R
    Cancer Res; 2018 May; 78(10):2760-2769. PubMed ID: 29540402
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Therapeutic m
    Wu S; Yun J; Tang W; Familiari G; Relucenti M; Wu J; Li X; Chen H; Chen R
    ACS Nano; 2023 Jun; 17(12):11838-11854. PubMed ID: 37310898
    [TBL] [Abstract][Full Text] [Related]  

  • 105. JMJD8 Functions as a Novel AKT1 Lysine Demethylase.
    Wang Y; Zhang Y; Li Z; Wang J
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613903
    [TBL] [Abstract][Full Text] [Related]  

  • 106. ALKBH5-Mediated m6A Demethylation of GLUT4 mRNA Promotes Glycolysis and Resistance to HER2-Targeted Therapy in Breast Cancer.
    Liu H; Lyu H; Jiang G; Chen D; Ruan S; Liu S; Zhou L; Yang M; Zeng S; He Z; Wang H; Li H; Zheng G; Liu B
    Cancer Res; 2022 Nov; 82(21):3974-3986. PubMed ID: 36069931
    [TBL] [Abstract][Full Text] [Related]  

  • 107. N6-methyladenosine demethylase ALKBH5 suppresses colorectal cancer progression potentially by decreasing PHF20 mRNA methylation.
    Zhang Z; Wang L; Zhao L; Wang Q; Yang C; Zhang M; Wang B; Jiang K; Ye Y; Wang S; Shen Z
    Clin Transl Med; 2022 Aug; 12(8):e940. PubMed ID: 35979628
    [TBL] [Abstract][Full Text] [Related]  

  • 108. The essential roles of m
    Ma L; Xue X; Zhang X; Yu K; Xu X; Tian X; Miao Y; Meng F; Liu X; Guo S; Qiu S; Wang Y; Cui J; Guo W; Li Y; Xia J; Yu Y; Wang J
    J Exp Clin Cancer Res; 2022 Jan; 41(1):36. PubMed ID: 35078505
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Gene-engineered exosomes-thermosensitive liposomes hybrid nanovesicles by the blockade of CD47 signal for combined photothermal therapy and cancer immunotherapy.
    Cheng L; Zhang X; Tang J; Lv Q; Liu J
    Biomaterials; 2021 Aug; 275():120964. PubMed ID: 34147721
    [TBL] [Abstract][Full Text] [Related]  

  • 110. mRNA therapeutics in cancer immunotherapy.
    Beck JD; Reidenbach D; Salomon N; Sahin U; Türeci Ö; Vormehr M; Kranz LM
    Mol Cancer; 2021 Apr; 20(1):69. PubMed ID: 33858437
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Posttranslational modification of pyruvate kinase type M2 (PKM2): novel regulation of its biological roles to be further discovered.
    Zheng S; Liu Q; Liu T; Lu X
    J Physiol Biochem; 2021 Aug; 77(3):355-363. PubMed ID: 33835423
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Folate Receptor-Mediated siRNA Delivery: Recent Developments and Future Directions for RNAi Therapeutics.
    Gangopadhyay S; Nikam RR; Gore KR
    Nucleic Acid Ther; 2021 Aug; 31(4):245-270. PubMed ID: 33595381
    [TBL] [Abstract][Full Text] [Related]  

  • 113. mRNA vaccine: a potential therapeutic strategy.
    Wang Y; Zhang Z; Luo J; Han X; Wei Y; Wei X
    Mol Cancer; 2021 Feb; 20(1):33. PubMed ID: 33593376
    [TBL] [Abstract][Full Text] [Related]  

  • 114. ALKBH5 Inhibited Cell Proliferation and Sensitized Bladder Cancer Cells to Cisplatin by m6A-CK2α-Mediated Glycolysis.
    Yu H; Yang X; Tang J; Si S; Zhou Z; Lu J; Han J; Yuan B; Wu Q; Lu Q; Yang H
    Mol Ther Nucleic Acids; 2021 Mar; 23():27-41. PubMed ID: 33376625
    [TBL] [Abstract][Full Text] [Related]  

  • 115. m
    Wang L; Hui H; Agrawal K; Kang Y; Li N; Tang R; Yuan J; Rana TM
    EMBO J; 2020 Oct; 39(20):e104514. PubMed ID: 32964498
    [TBL] [Abstract][Full Text] [Related]  

  • 116. ALKBH5 suppresses malignancy of hepatocellular carcinoma via m
    Chen Y; Zhao Y; Chen J; Peng C; Zhang Y; Tong R; Cheng Q; Yang B; Feng X; Lu Y; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2020 Aug; 19(1):123. PubMed ID: 32772918
    [TBL] [Abstract][Full Text] [Related]  

  • 117. ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment.
    Li N; Kang Y; Wang L; Huff S; Tang R; Hui H; Agrawal K; Gonzalez GM; Wang Y; Patel SP; Rana TM
    Proc Natl Acad Sci U S A; 2020 Aug; 117(33):20159-20170. PubMed ID: 32747553
    [TBL] [Abstract][Full Text] [Related]  

  • 118. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
    Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
    Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
    [TBL] [Abstract][Full Text] [Related]  

  • 119. RNA Demethylase ALKBH5 Selectively Promotes Tumorigenesis and Cancer Stem Cell Self-Renewal in Acute Myeloid Leukemia.
    Shen C; Sheng Y; Zhu AC; Robinson S; Jiang X; Dong L; Chen H; Su R; Yin Z; Li W; Deng X; Chen Y; Hu YC; Weng H; Huang H; Prince E; Cogle CR; Sun M; Zhang B; Chen CW; Marcucci G; He C; Qian Z; Chen J
    Cell Stem Cell; 2020 Jul; 27(1):64-80.e9. PubMed ID: 32402250
    [TBL] [Abstract][Full Text] [Related]  

  • 120. m
    Jin D; Guo J; Wu Y; Yang L; Wang X; Du J; Dai J; Chen W; Gong K; Miao S; Li X; Sun H
    Mol Cancer; 2020 Feb; 19(1):40. PubMed ID: 32106857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.